1.
Nan D, Abraira-Meriel C, de la Roz-Fernandez S, Maestre-Orozco T, Hernandez JL, Fernandez-Ayala M. Delayed Use of the Recombinant Human IL-1 Receptor Antagonist Anakinra in Five COVID-19 Patients with Pulmonary Fibrosis and Persistent Hypoxaemia: A Preliminary Report. EJCRIM 2021;8 doi:10.12890/2021_002821.